KinetiSol® technology: scale-up approach
This presentation highlights Justin Keen, Senior Vice President of Operations at AustinPx, as he delves into KinetiSol technology—a groundbreaking method for creating amorphous solid dispersions. Discover how KinetiSol addresses the challenges of developing poorly soluble drugs.
Keen explains how process development goals evolve alongside product progression, ensuring streamlined manufacturing for both clinical trials and commercial production. Real-world examples demonstrate the impact of process parameters on the quality of the final product.
Key insights include:
- Enhanced Bioavailability: Boost absorption of poorly soluble drugs.
- Accelerated Development: Save valuable time with KinetiSol's solvent-free, fusion-based process.
- Cutting-Edge Innovation: Explore a next-generation approach to manufacturing amorphous dispersions.
Comments
No comments posted yet.